Skip to main content
OpenTrials
Completed

NCT Number: NCT07101198

Ultrasound-Guided Erector Spinae Plane Block in Major Spinal Surgery

This study aims to evaluate the effects of ultrasound-guided bilateral erector spinae plane block on intraoperative pain control and bleeding in patients undergoing major spinal surgery. Participants will be randomly assigned to two groups: one group will receive the Erector Spinae Plane block, while the other group will receive standard pain management. Primary outcomes include postoperative pain levels and intraoperative blood loss. This study seeks to determine whether the Erector Spinae Plane Block technique positively contributes to patient recovery and reduces bleeding complications.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Etlik city hospital

Ankara, Turkey (Türkiye)

About this study

This randomized controlled trial investigates the effectiveness of ultrasound-guided bilateral Erector Spinae Plane Block on intraoperative opioid consumption and bleeding in patients undergoing spinal surgery. Eligible adult patients will be enrolled after obtaining informed consent.

Participants will be randomly assigned to two groups: the intervention group will receive bilateral Erector Spinae Plane Block under ultrasound guidance before surgery, while the control group will receive standard pain management without the block. The Erector Spinae Plane Block will be performed using a standard dose of bupivacaine.

The primary outcome measure is the amount of intraoperative bleeding. Secondary outcomes include opioid consumption and incidence of complications.

This study aims to provide evidence on the efficacy of the Erector Spinae Plane Block technique in improving postoperative recovery and reducing bleeding complications in major spinal surgeries.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years or older

Scheduled for elective spinal stabilization surgery

American Society of Anesthesiologists (ASA) physical status I-III

Provided written informed consent

Exclusion criteria

Coagulopathy or current anticoagulant therapy

Anatomical barrier or infection at the Erector Spinae Plane Block site

Known allergy to local anesthetics or opioids

-

Treatment and study plan

Ultrasound-Guided Erector Spinae Plane Block

Procedure

Patients in this group will receive an ultrasound-guided erector spinae plane block 30 minutes before surgery. A total volume of bupivacaine will be injected bilaterally into the fascial plane between the erector spinae muscle and the transverse process. All patients will also receive standard postoperative analgesia.

Primary outcomes

  1. Intraoperative estimated blood loss

    Time frame: During surgery

    Intraoperative estimated blood loss (milliliters) Total amount of blood lost during surgery will be measured in milliliters. [Time Frame: During surgery]

Secondary outcomes

  1. Total intraoperative remifentanil consumption

    Time frame: During surgery

    The total dose of remifentanil administered intraoperatively (in micrograms) will be recorded by the anesthesia team.

Sponsors and collaborators

Lead sponsor

Diskapi Yildirim Beyazit Education and Research Hospital

Other Gov

Registry information

Official study title

Evaluation of the Effectiveness of Ultrasound-Guided Bilateral Erector Spinae Plane Block on Postoperative Pain and Bleeding in Major Spinal Surgery

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 3, 2025
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.